EXPERIENCE WITH THE OXFORD TUMOUR MARKER (Ca1) IN SEROUS FLUIDS
- 11 June 1983
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 321 (8337) , 1326
- https://doi.org/10.1016/s0140-6736(83)92430-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONSThe Lancet, 1982
- Identification of Hodgkin and sternberg‐reed cells as a unique cell type derived from a newly‐detected small‐cell populationInternational Journal of Cancer, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 3. IMMUNOCYTOCHEMICAL DETECTION OF MALIGNANT CELLS IN SEROUS FLUIDS WITH THE Cal ANTIBODYThe Lancet, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 2. IMMUNOHISTOCHEMICAL DETECTION OF THE Ca ANTIGEN IN HUMAN TISSUES WITH THE Ca1 ANTIBODYThe Lancet, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 1. THE Ca ANTIGEN AND THE Cal ANTIBODYThe Lancet, 1982